David Mou, MD, was appointed as Mr. Robertson’s replacement, the report said. Dr. Mou is Cerebral’s president and chief medical officer.
The company had paused controlled substances prescriptions for new patients earlier in the week, and some retail pharmacies stopped filling Cerebral prescriptions for Adderall, a stimulant used to treat ADHD.